Biohaven’s (BHVN) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright restated their buy rating on shares of Biohaven (NYSE:BHVN – Free Report) in a research note released on Tuesday morning, Benzinga reports. The firm currently has a $59.00 price objective on the stock. Several other analysts have also weighed in on BHVN. Piper Sandler upped their target price on Biohaven from $66.00 to […]
Mogo’s (MOGO) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright restated their buy rating on shares of Mogo (NASDAQ:MOGO – Free Report) in a research note released on Tuesday, Benzinga reports. They currently have a $6.00 target price on the stock. Mogo Stock Performance Shares of MOGO opened at $1.22 on Tuesday. The company has a debt-to-equity ratio of 0.45, a current ratio […]
Evaxion Biotech A/S’s (EVAX) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright reissued their buy rating on shares of Evaxion Biotech A/S (NASDAQ:EVAX – Free Report) in a report issued on Friday morning, Benzinga reports. They currently have a $14.00 target price on the stock. Evaxion Biotech A/S Price Performance EVAX stock opened at $2.95 on Friday. Evaxion Biotech A/S has a 52-week low of […]
Hut 8’s (HUT) Buy Rating Reiterated at HC Wainwright
HC Wainwright reiterated their buy rating on shares of Hut 8 (NASDAQ:HUT – Free Report) in a research report report published on Friday morning, Benzinga reports. HC Wainwright currently has a $13.50 price objective on the stock. Other equities analysts also recently issued reports about the company. Needham & Company LLC restated a buy rating […]
last updated on 27 Sep 19:24